当前位置:首页 - 行情中心 - 毕得医药(688073) - 财务分析 - 现金流量表

毕得医药

(688073)

  

流通市值:53.24亿  总市值:53.24亿
流通股本:9088.29万   总股本:9088.29万

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金717,469,006.8339,186,076.921,390,422,606.81929,154,255.85
  收到的税费返还45,615,186.418,627,108.7458,380,404.2240,429,228.34
  收到其他与经营活动有关的现金10,112,490.975,603,930.9532,097,312.8327,621,571.67
  经营活动现金流入小计773,196,684.17363,417,116.611,480,900,323.86997,205,055.86
  购买商品、接受劳务支付的现金444,799,721.95230,829,051.991,096,532,777.85747,272,107.11
  支付给职工以及为职工支付的现金108,902,332.4650,988,612.73191,194,781.07134,615,488.48
  支付的各项税费88,386,357.5819,238,595.2972,729,944.2838,142,548.69
  支付其他与经营活动有关的现金39,482,763.2422,929,938.8692,118,605.3568,442,207.2
  经营活动现金流出小计681,571,175.23323,986,198.871,452,576,108.55988,472,351.48
  经营活动产生的现金流量净额91,625,508.9439,430,917.7428,324,215.318,732,704.38
二、投资活动产生的现金流量:
  收回投资收到的现金1,378,000,000460,009,535.314,227,594,468.943,339,081,843.86
  取得投资收益收到的现金2,625,997.12696,350.688,880,517.754,708,553.48
  处置固定资产、无形资产和其他长期资产收回的现金净额12,636,429.0612,683,830.4310,052,865.112,758,643.34
  收到的其他与投资活动有关的现金8,000,0008,000,00014,480,00011,644,185.16
  投资活动现金流入小计1,401,262,426.18481,389,716.424,261,007,851.793,368,193,225.84
  购建固定资产、无形资产和其他长期资产支付的现金3,902,179.921,769,110.9424,283,902.112,702,136.86
  投资支付的现金1,428,000,000570,000,0004,282,375,4673,457,375,467
  取得子公司及其他营业单位支付的现金1,767,2961,771,366.47,016,125.46-
  支付其他与投资活动有关的现金--22,480,000.2216,544,185.2
  投资活动现金流出小计1,433,669,475.92573,540,477.344,336,155,494.783,486,621,789.06
  投资活动产生的现金流量净额-32,407,049.74-92,150,760.92-75,147,642.99-118,428,563.22
三、筹资活动产生的现金流量:
  取得借款收到的现金38,466.12137,099.4250,709,341.29276,952,760.48
  收到其他与筹资活动有关的现金4,982,694.44-4,982,515.562,982,515.56
  筹资活动现金流入小计5,021,160.56137,099.4255,691,856.85279,935,276.04
  偿还债务支付的现金2,591,215.452,591,215.45194,282,470.22118,645,192.18
  分配股利、利润或偿付利息支付的现金100,897,968.77659,336.4279,786,387.2878,888,900.58
  支付其他与筹资活动有关的现金7,734,775.373,785,671.68119,658,025.44112,321,417.35
  筹资活动现金流出小计111,223,959.597,036,223.55393,726,882.94309,855,510.11
  筹资活动产生的现金流量净额-106,202,799.03-6,899,124.15-138,035,026.09-29,920,234.07
四、汇率变动对现金及现金等价物的影响-19,874,630-8,910,177.57-8,774,772.59-3,268,217.27
五、现金及现金等价物净增加额-66,858,969.83-68,529,144.9-193,633,226.36-142,884,310.18
  加:期初现金及现金等价物余额902,987,471.89902,987,471.891,096,620,698.251,096,620,698.25
  期末现金及现金等价物余额836,128,502.06834,458,326.99902,987,471.89953,736,388.07
补充资料:
  净利润103,303,996.81-151,739,651.59-
  资产减值准备21,389,122.23-41,022,275.45-
  固定资产和投资性房地产折旧7,341,781.84-13,985,751.95-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧7,341,781.84-13,985,751.95-
  无形资产摊销344,749.56-497,471.38-
  长期待摊费用摊销4,385,215.32-9,381,954.28-
  处置固定资产、无形资产和其他长期资产的损失-4,842,482.5--3,898,219.62-
  固定资产报废损失--1,113,604.89-
  公允价值变动损失-1,633,661.29--2,599,122.99-
  财务费用27,447,440.32-13,228,303.72-
  投资损失-1,176,349.53--7,983,317.65-
  递延所得税-3,904,534.69--4,748,763.14-
  其中:递延所得税资产减少-2,683,486.67--5,254,090.31-
    递延所得税负债增加-1,221,048.02-505,327.17-
  存货的减少16,649,654.72--231,935,304.96-
  经营性应收项目的减少-18,294,389.15--29,757,507.3-
  经营性应付项目的增加-32,154,781.57-24,935,738.22-
  其他-36,828,068.87-33,509,597.5-
  不涉及现金收支的投资和筹资活动金额其他项目0-16,533,081.74-
  现金的期末余额836,128,502.06-902,987,471.89-
  减:现金的期初余额902,987,471.89-1,096,620,698.25-
  现金及现金等价物的净增加额-66,858,969.83--193,633,226.36-
公告日期2026-08-282026-04-302026-04-232025-10-30
审计意见(境内)标准无保留意见
TOP↑